Drug addiction is a neurological condition. If your use has become something you can no longer simply decide to stop, that is not a personal failing, it is the condition working exactly as the science predicts it will. The same part of the brain you need to make the decision to stop is the part most affected by sustained drug use. This is why it does not respond to willpower alone, and why the right support is not a luxury, it is structurally necessary.
This page is written by a team that includes people who have been through drug addiction themselves. Not as observers. As people who once sat where you might be sitting now.
Drug addiction is a chronic condition in which a person continues to use a substance compulsively, despite clear harm to their health, relationships, or daily life. It is recognised internationally as a medical condition — by the World Health Organisation, the National Institute on Drug Abuse, and UK clinical guidelines — not a moral failing and not a lack of willpower.
What happens in the brain is well understood. Addictive substances trigger dopamine surges far beyond anything produced by natural rewards. With repeated use, the brain recalibrates around the drug: receptor sensitivity drops, tolerance builds, and natural sources of motivation lose their pull. The prefrontal cortex — responsible for judgement and impulse control — shows reduced activity. The part of the brain a person needs most to decide to stop is the part most weakened by the using.
This is why people who are addicted so often describe a specific frustration: they can see the problem clearly, they want to stop, and they cannot. It is not a contradiction. It is the architecture of the condition.
All addictive substances affect dopamine, but the dependency they produce, the speed at which it takes hold, and the risks of stopping vary considerably.
Opioids, including heroin and prescription painkillers, produce rapid physical dependency with severe withdrawal. Opiates account for 42% of the adult treatment population in England. Our page on heroin addiction covers the patterns in detail.
Stimulants, including cocaine and amphetamines, tend toward a binge-and-crash cycle with intense psychological pull. Our page on cocaine addiction covers the specific cycle.
Depressants, including benzodiazepines and sedatives, produce physical dependency that can be medically dangerous to withdraw from unsupervised. In 2023–24, 3,872 new adults entered treatment for benzodiazepine problems.
Cannabis produces less physical withdrawal but can create persistent psychological dependency, particularly with the high-potency varieties now dominating the UK market. Our page on cannabis addiction covers what this looks like.
Ketamine treatment presentations have risen sharply — 3,609 people entered treatment in 2023–24, more than eight times the number in 2014–15. Our page on ketamine addiction covers the specific risks.
In 2024–25, 329,646 adults were in contact with drug and alcohol treatment services in England — the highest number since reporting began. Of those, 169,542 were new entrants, also a record. Just over two-fifths were in treatment for opiates.
The Crime Survey for England and Wales (year ending March 2025) estimates that 2.9 million adults aged 16 to 59 used drugs in the previous 12 months — around 8.7% of the population. Among 16- to 24-year-olds, the figure was 15.1%. In 2023, 5,448 drug-related deaths were registered in England and Wales, an 11% increase on the previous year.
The profile is shifting. The opiate treatment population is ageing. Ketamine and benzodiazepine use is rising among younger adults. And the 2025 Adult Psychiatric Morbidity Survey (City St George’s, University of London) found that only about one in five adults showing signs of drug dependence had ever received any form of support. The actual scale of drug dependency in the UK is substantially larger than the treatment data suggests.
Drug addiction presents itself through a series of shifts that each feel manageable at the time — until the distance between where you started and where you are becomes undeniable.
You might notice that the amount you use has crept up without a conscious decision to increase it. That you’ve started planning your time around using, or recovering from using. That you’ve tried to stop or cut down and found that the decision holds for a day, or a few hours, and then doesn’t. You cancel things not because you don’t want to go, but because you can’t guarantee what state you’ll be in. Things you used to care about have started to lose their pull, drug use has slowly reorganised what matters.
From the outside, the people closest to you see a different set of changes: secrecy where there used to be openness, unreliability where there used to be consistency, a version of you they recognise less and less.
The brain changes that drive drug addiction are real. They are not permanent. The same neuroplasticity that allows addiction to take hold also allows the brain to recover, given the right conditions and enough time.
The treatment data bears this out: 46% of people who completed treatment in England in 2024–25 were discharged free from dependence. Tens of thousands of people whose brains were given the conditions to begin recovering and did.
Those conditions are specific. They require a change of environment, because the environment a person uses in is wired into the dependency. They require consistent support, because the early stages of recovery are when the brain is least equipped to sustain its own resolve. And they require time.
For many people, that starts with detox — a medically supported process that allows the body to stabilise. What follows is structured treatment that addresses the drivers underneath the use, not just the use itself. Drug rehab provides that structure in a setting designed to interrupt the cycle at its root.
The fact that you’re here trying to understand what is happening, whether for yourself or for someone you care about, is an important step. Recognition is where every recovery begins.
At Abbington House, treatment takes place within a small residential community of no more than 24 people, supported by a team that includes people who have been through addiction themselves and understand what the work of recovery actually involves. The approach is abstinence-based, trauma-informed, and built around the 12-step model. It is drug rehab for people who need a different environment and consistent, daily support.
You can get in touch confidentially. Call 01438 583222
Reviewed by Michael Williams, Treatment Manager, Abbington House.
